Trupanion, Inc. (NASDAQ:TRUP – Free Report) – Equities researchers at William Blair reduced their Q3 2025 EPS estimates for shares of Trupanion in a research report issued on Thursday, February 20th. William Blair analyst B. Vazquez now anticipates that the financial services provider will earn $0.02 per share for the quarter, down from their prior forecast of $0.03. The consensus estimate for Trupanion’s current full-year earnings is $0.13 per share. William Blair also issued estimates for Trupanion’s Q4 2025 earnings at $0.14 EPS, FY2025 earnings at $0.07 EPS, Q3 2026 earnings at $0.03 EPS, Q4 2026 earnings at $0.18 EPS and FY2026 earnings at $0.17 EPS.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The financial services provider reported $0.04 EPS for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The business had revenue of $337.31 million for the quarter, compared to analysts’ expectations of $335.41 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.11%.
Check Out Our Latest Stock Report on TRUP
Trupanion Stock Performance
Shares of TRUP stock opened at $35.40 on Friday. The stock has a market capitalization of $1.50 billion, a P/E ratio of -153.91, a PEG ratio of 8.29 and a beta of 1.60. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm’s 50 day moving average is $48.04 and its 200 day moving average is $47.89. Trupanion has a 12 month low of $19.69 and a 12 month high of $57.90.
Hedge Funds Weigh In On Trupanion
Several institutional investors and hedge funds have recently bought and sold shares of TRUP. FMR LLC grew its position in Trupanion by 55,963.7% during the 3rd quarter. FMR LLC now owns 1,172,293 shares of the financial services provider’s stock worth $49,213,000 after acquiring an additional 1,170,202 shares during the last quarter. Balyasny Asset Management L.P. grew its position in Trupanion by 368.2% during the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider’s stock worth $40,548,000 after acquiring an additional 661,559 shares during the last quarter. BNP Paribas Financial Markets grew its position in Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider’s stock worth $16,248,000 after acquiring an additional 212,545 shares during the last quarter. Freestone Grove Partners LP bought a new position in Trupanion during the 4th quarter worth approximately $7,776,000. Finally, Baillie Gifford & Co. grew its position in Trupanion by 26.6% during the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after acquiring an additional 147,341 shares during the last quarter.
Insider Activity at Trupanion
In other Trupanion news, SVP Emily Dreyer sold 900 shares of the company’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $54.55, for a total transaction of $49,095.00. Following the completion of the sale, the senior vice president now directly owns 23,808 shares in the company, valued at $1,298,726.40. This represents a 3.64 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Fawwad Qureshi sold 622 shares of Trupanion stock in a transaction dated Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total value of $32,723.42. Following the completion of the transaction, the chief financial officer now owns 9,867 shares in the company, valued at approximately $519,102.87. This represents a 5.93 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,581 shares of company stock valued at $615,159. Corporate insiders own 5.50% of the company’s stock.
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Read More
- Five stocks we like better than Trupanion
- Learn Technical Analysis Skills to Master the Stock Market
- These 4 Low P/E Tech Stocks Could be Breakout-Ready Bargains
- The 3 Best Retail Stocks to Shop for in August
- Palantir Stock Skids—How Much Further Can It Fall?
- Trading Stocks: RSI and Why it’s Useful
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.